Related Experiment Videos
Central post-stroke pain syndrome: yet another use for gabapentin?
Boqing Chen1, Todd P Stitik, Patrick M Foye
1Department of Physical Medicine and Rehabilitation, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103-2499, USA.
American Journal of Physical Medicine & Rehabilitation
|August 13, 2002
Summary
Gabapentin effectively treated central post-stroke pain syndrome in a patient unresponsive to other analgesics. This medication shows promise for managing central nervous system pain conditions.
Area of Science:
- Neurology
- Pain Management
- Pharmacology
Background:
- Gabapentin, initially for seizures, is primarily used for peripheral neuropathic pain.
- Limited data exists on gabapentin's efficacy for central nervous system (CNS) pain.
- Central post-stroke pain syndrome (CPSP) is a challenging condition often refractory to standard treatments.
Observation:
- A 45-year-old male patient presented with CPSP.
- The patient had not responded to various oral analgesic medications.
- Gabapentin therapy was initiated for his condition.
Findings:
- Significant pain reduction was observed within two weeks of gabapentin initiation.
- The patient experienced notable improvements in functional levels.
- Gabapentin demonstrated a positive therapeutic effect on CPSP symptoms.
Implications:
- Gabapentin may be a viable treatment option for central post-stroke pain syndrome.
- Further research is warranted to explore gabapentin's role in CNS pain management.
- This case highlights the potential of gabapentin beyond its established indications.